1- Professor of Neurosurgery, Department of Neurosurgery, School of Medicine, Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Department of Anesthesiology, Critical Care and Pain Management Research Center, Jahrom University of Medical Sciences, Jahrom, Iran
3- Faculty Member, Jahrom University of Medical Sciences, Medical School, Department of Bacteriology and Virology, Jahrom, Iran
4- Department of Neurosurgery, Peymanieh Hospital, Trauma Research Center, Jahrom University of Medical Sciences, Jahrom, Iran , kazemimd@msn.com
Abstract: (1917 Views)
Background and Aim: The viral agent in severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) is the cause of the novel coronavirus disease 2019 (COVID-19). It was first identified in December 2019 in the city of Wuhan, Hubei, China, and the World Health Organization declared it as an outbreak and a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. Neurosurgeons are not prime in COVID-19 management but they continue for caring, visiting, and operating neurosurgical patients. In neurosurgical cases that need non-urgent operation, systematic SARS-CoV-2 testing of low-risk patients should be considered. In cases with positive SRAS-COV-2 testing, the procedures should be delayed until they are cured. The high-risk settings in the neurosurgical operation room are endotracheal intubation and extubation, operations in the vicinity of sinuses and/or mastoids, operations with accidental injury to respiratory or digestive tracts, and usage of aerosol-generating instruments on virioncontaminated tissues. The risk of SARS-COV-2 infection is decreased by delaying all nonemergent cases, replacing general anesthesia with other anesthesia methods, replacing neurosurgical approaches with alternative approaches that bypass the respiratory tract, and decreasing the usage of aerosol-generating instruments.
Methods and Materials/Patients: This is a narrative study about COVID-19 infection in neurosurgery. Using the keywords SARS-COV2, neurosurgery, and COVID-19, all the relevant articles (about 52) were retrieved from Google Scholar, Medline, and PubMed and reviewed and
critically analyzed.
Results: Neurosurgeons can change neurosurgical routines in COVID-19 patients such as delaying all nonemergent cases, replacing general anesthesia with other anesthesia methods, replacing neurosurgical approaches with alternative approaches that bypass the respiratory tract, decreasing the usage of aerosol-generating instruments, and doing preoperative SRAS-COV-2 testing.
Conclusion: For decreasing the risk of COVID-19 transmission in neurosurgery, we can change routine neurosurgical protocols. Without the prevention of COVID-19 transmission, all neurosurgeons, personnel, and patients will contract COVID-19.
Article number: 3
Full Text [PDF 828 kb]
(614 Downloads)
| |
Full Text (HTML) (846 Views)
● Because of direct contact during surgery between neurosurgeons and their patients, all neurosurgeons, and the surgical team must be protected from contracting COVID-19.
● In cases that need a non-urgent operation, systematic SARS-CoV-2 testing of low-risk patients (asymptomatic and no history of travel or contact with COVID-19 patients) should be considered. After doing preoperative SRAS-COV-2 testing, in infected patients, if possible, delaying the procedures until they are cured and in negative cases, decreasing the usage of protective equipment should be regarded.
● There is a lower risk of SARS-COV-2 with :after delaying all nonemergent cases, replacing general anesthesia with other anesthesia methods if possible, replacing neurosurgical approaches with alternative approaches that bypass the respiratory tract, and decreasing the usage of aerosol-generating instruments, including drills, electrocautery, ultrasonic aspirators, lasers, and carbon dioxide insufflators.
Type of Study:
Review |
Subject:
Basic Neurosurgery